An observational study in Post COVID-19 Condition, sponsored by Medical University Innsbruck. Status unknown at 1 site in Austria. Per ClinicalTrials.gov, last updated 2022-09-19.
Sponsored by Medical University Innsbruck · Observational
Longitudinal, prospective observational cohort study enrolling patients with persisting symptoms (> 12 weeks) after COVID-19 in a multidisciplinary care model.
Post-COVID-19 syndrome comprises a set of persistent physical, cognitive and/or psychological symptoms that continue for more than 12 weeks after illness and are not attributable to alternative diagnoses. As these symptoms may manifest in all COVID-19 severity grades, even in patients with mild or moderate disease, there is an urgent need for resource allocation in the health care system and accompanied research proposals to understand disease phenotypes and clinical trajectories.
With this prospective multidisciplinary registry, the investigators aim to establish a clinical and researchbased system by providing optimized medical diagnostic and therapeutic approaches in a model region in Austria (Tyrol).
536 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 187 are open to participants now.
This study's planned enrollment of 600 is above the median of 160 across 149 observational studies indexed under Post-Acute COVID-19 Syndrome.
Browse Post-Acute COVID-19 Syndrome studies →Medical University Innsbruck is the lead sponsor of 186 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Eligible patients will be screened by primary physicians in Tyrol (Wester Austria) using the post-COVID-19 functional status (PCFS) scale to assess the functional status, and a symptom checklist for the presence and severity of the 10 most common symptoms.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prevalence rates of post-COVID patients requiring multidisciplinary care.
To quantify disease burden by prevalence rates of post-COVID patients requiring multidisciplinary care.
Time frame: 2 years
Characterisation of symptom patterns associated with impaired functional status.
Characterisation of symptom patterns associated with impaired post covid-19 functional status scale ≥ 2.
Time frame: up to 24 months
Plan to share: Yes — We provide all of the individual participant data collected during the trial after deidentification and to researchers who provide a methodologically sound proposal.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code
Time frame: Beginning three months after publication and ending five years following article publication.
Access criteria: Access to researchers who provide a methodologically sound proposal.
No publications or documents are linked to this record.
This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Post-Acute COVID-19 Syndrome →
Medical University Innsbruck →